SARS-CoV-2 Inactivated Vaccine in Naïve ANCA-Associated Vasculitis: Impact of Glucocorticoid Use

2022 ◽  
Author(s):  
Rosa Maria Rodrigues Pereira ◽  
Marilia A. Dagostin ◽  
Valeria F. Caparbo ◽  
Lucas P. Sales ◽  
Sandra Gofinet Pasoto ◽  
...  
Keyword(s):  
Inactivated Vaccine ◽  
Anca Associated Vasculitis

Familial Risk Found to Be Low For ANCA-Associated Vasculitis

2008 ◽  
Vol 39 (3) ◽  
pp. 52
Author(s):  
DIANA MAHONEY
Keyword(s):  
Familial Risk ◽  
Anca Associated Vasculitis

Propylthiouracil-induced ANCA-associated vasculitis and agranulocytosis in a patient with Graves' disease

2019 ◽  
Author(s):  
Maria Tomkins ◽  
Diarmuid Smith ◽  
Amar Agha
Keyword(s):  
Graves Disease ◽  
Anca Associated Vasculitis

Comparative study between prepared bivalent IB inactivated vaccine and commercial one

2019 ◽  
Vol 36 (2) ◽  
pp. 392-405
Author(s):  
Reda Fathy ◽  
Magda Moustafa ◽  
Kamel Zyan ◽  
Ibrahim ElBorai ◽  
Susan El-Mahdy
Keyword(s):  
Comparative Study ◽  
Inactivated Vaccine

Biologics for ANCA-Associated Vasculitis

2014 ◽  
Vol 13 (4) ◽  
pp. 275-287 ◽  
Author(s):  
Giuseppe Murgia ◽  
Davide Firinu ◽  
Paolo Manconi ◽  
Stefano Giacco
Keyword(s):  
Anca Associated Vasculitis

scholarly journals Updating OMERACT Core Set of Domains for ANCA-associated Vasculitis: Patient Perspective Using the International Classification of Function, Disability, and Health

2019 ◽  
Vol 46 (10) ◽  
pp. 1415-1420 ◽  
Author(s):  
Nataliya Milman ◽  
Eilish McConville ◽  
Joanna C. Robson ◽  
Annelies Boonen ◽  
Peter Tugwell ◽  
...  
Keyword(s):  
The United States ◽  
International Classification ◽  
Antineutrophil Cytoplasmic Antibodies ◽  
Personal Factors ◽  
Disability And Health ◽  
Individual Interviews ◽  
The United Kingdom ◽  
Anca Associated Vasculitis ◽  
Core Set

Objective.Aspects of antineutrophil cytoplasmic antibodies–associated vasculitis (AAV) prioritized by patients with AAV were described using the International Classification of Function, Disability, and Health (ICF).Methods.Items identified during 14 individual interviews were incorporated into an ICF-based questionnaire administered to participants of 2 vasculitis patient symposia: 36 in the United Kingdom and 63 in the United States.Results.Categories identified as at least “moderately relevant” by ≥ 5% of subjects included 44 body functions, 14 body structures, 35 activities and participation, 31 environmental factors, and 38 personal factors.Conclusion.Identified categories differ from those identified by the current Outcome Measures in Rheumatology (OMERACT) core set and those prioritized by vasculitis experts.

scholarly journals The case for replacing live oral polio vaccine with inactivated vaccine in the Americas

The Lancet ◽  
2020 ◽  
Vol 395 (10230) ◽  
pp. 1163-1166
Author(s):  
Jorge A Alfaro-Murillo ◽  
Marí L Ávila-Agüero ◽  
Meagan C Fitzpatrick ◽  
Caroline J Crystal ◽  
Luiza-Helena Falleiros-Arlant ◽  
...  
Keyword(s):  
Oral Polio Vaccine ◽  
Inactivated Vaccine ◽  
Polio Vaccine
Sign in / Sign up

Export Citation Format

Share Document